英文名称 |
中文名称 |
CAS号 |
操作 |
1H-Benzimidazole-5-carboxylic acid, 2-[[[4-[(E)-amino[[(hexyloxy)carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl- |
达比加群酯杂质67 |
2459303-30-9 |
详细
|
benzofuran-6-carboxylic acid(Lifitegrast Impurity 29) |
苯并呋喃-6-羧酸( 立他司特杂质) |
77095-51-3 |
详细
|
Dabigatran iMpurity F |
达比加群杂质F |
1642853-67-5 |
详细
|
INDEX NAME NOT YET ASSIGNED |
达比加群酯杂质 |
2518152-88-8 |
详细
|
N-Desethyl Vardenafil |
N-去乙基伐地那非(伐地那非杂质) |
448184-46-1 |
详细
|
Dabigatran iMpurity O |
达比加群杂质O |
948551-71-1 |
详细
|
Dabigatran Impurity 29 |
达比加群酯杂质29 |
1610758-21-8 |
详细
|
Linagliptin Impurity F |
利格列汀杂质F |
1673546-62-7 |
详细
|
ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride |
达比加群杂质J |
1354727-65-3 |
详细
|
Dabigatran Impurity 38 |
达比加群杂质38 |
1416446-40-6 |
详细
|
β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester |
达比加群甲酯杂质 |
771459-37-1 |
详细
|
Dabigatran Etexilate Impurity 67 |
达比加群酯杂质67 |
1848337-06-3 |
详细
|
Linagliptin Impurity 51 |
利格列汀杂质51 |
2138392-83-1 |
详细
|
(R)-4-Hydroxy-2-pyrrolidone |
奥拉西坦杂质A |
62624-29-7 |
详细
|
Hydroxyvardenafil |
羟基伐地那非(伐地那非杂质) |
224785-98-2 |
详细
|
Dabigatran Etexilate Impurity O HCl |
达比加群酯杂质O盐酸盐 |
211914-50-0 |
详细
|
Dabigatran iMpurity K |
达比加群杂质K |
1580491-16-2 |
详细
|
Linagliptin iMpurity E |
利拉利汀杂质E |
1446263-38-2 |
详细
|
Dabigatran Impurity 18 |
达比加群杂质 18 |
1422435-35-5 |
详细
|
Sodium sarcosinate |
肌氨酸钠 |
4316-73-8 |
详细
|
(R)-4-Hydroxy-2-pyrrolidone |
奥拉西坦杂质A |
22677-21-0 |
详细
|
Dabigatran etexilate C5 |
达比加群酯杂质C5 |
1416446-45-1 |
详细
|
Cyanamide, N,N-dicyano- |
磷酸肌酸钠杂质 |
97904-31-9 |
详细
|
Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate |
3-[(3-氨基-4-甲基氨基苯甲酰)吡啶-2-基氨基]丙酸乙酯(达比加群杂质) |
212322-56-0 |
详细
|
midazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-hydroxyphenyl)-5-methyl-7-propyl- |
伐地那非杂质 |
910554-78-8 |
详细
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-5,7-dimethyl- |
伐地那非杂质 |
224785-72-2 |
详细
|
Dabigatran iMpurity G |
达比加群杂质G |
1912458-32-2 |
详细
|
Dabigatran Etexilate Impurity X |
达比加群酯杂质X |
1643377-48-3 |
详细
|
Dabigatran Impurity 9 |
达比加群酯杂质9 |
1408238-41-4 |
详细
|
Linagliptin impurity 16 |
利拉利汀杂质16 |
1955514-80-3 |
详细
|
(S)-2-(tert-butoxycarbonylamino)-3-(3-(methylsulfonyl)phenyl) propanoic acid |
BOC-3-砜基苯丙氨酸(立他司特杂质C-1) |
1289646-76-9 |
详细
|
GLYCINE ANHYDRIDE |
甘氨酸酐(奥拉西坦相关) |
106-57-0 |
详细
|
Linagliptin Impurity 14 |
利格列汀杂质14 |
2416949-69-2 |
详细
|
β-Alanine, N-[[2-[[[4-[(E)-amino[[[(4-methylpentyl)oxy]carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester |
达比加群杂质20 |
1873316-88-1 |
详细
|
β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, labeled with tritium |
达比加群酯杂质B |
1919877-45-4 |
详细
|
β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, hydrochloride (1:) |
达比加群酯杂质O盐酸盐 |
1187067-70-4 |
详细
|
Dabigatran iMpurity D |
达比加群杂质D |
1610758-22-9 |
详细
|
Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate (Dabigatran IMpurity) |
达比加群酯杂质G |
1408238-36-7 |
详细
|
4-Aminobenzamidine dihydrochloride |
4-氨基苯甲脒二盐酸盐(达比加群杂质) |
2498-50-2 |
详细
|
Dabigatran Impurity 10 (DABRC-10) |
达比加群杂质10(DABRC-10) |
1304574-20-6 |
详细
|
Vardenafil Impurity 7 |
伐地那非杂质 7 |
1009013-42-6 |
详细
|
9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate |
二丙酸倍他米松EP杂质B |
5534-13-4 |
详细
|
4-hydroxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazine-2-yl)phenylsulfonic acid |
伐地那非杂质 |
910554-77-7 |
详细
|
Desethyl Dabigatran Etexilate |
去乙基达比加群酯(达比加群酯杂质) |
212321-78-3 |
详细
|
oxiracetam impurity III |
奥拉西坦杂质III |
62833-66-3 |
详细
|
Vardenafil EP Impurity B |
伐地那非EP杂质B |
437717-43-6 |
详细
|
Dabigatran iMpurity L |
达比加群杂质L |
1422435-41-3 |
详细
|
Dabigatran etexilate Imp.C |
达比加群酯杂质C |
1408238-40-3 |
详细
|
Dabigatran Etexilate iMpurity C4 |
邻丁基达比加群乙酯(达比加群杂质) |
1416446-43-9 |
详细
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-ethoxyphenyl)-5,7-dimethyl- |
伐地那非杂质 |
224789-20-2 |
详细
|
oxiracetam impurity VI |
奥拉西坦杂质VI |
85614-52-4 |
详细
|
(R)-4-Hydroxy-2-pyrrolidone |
奥拉西坦杂质A |
25747-41-5 |
详细
|
Dabigatran Etexilate Impurity B |
达比加群酯杂质B |
211914-51-1 |
详细
|
3-(pyridin-2-ylamino)propanoic acid |
3-(2-吡啶胺)丙酸(达比加群杂质) |
104961-64-0 |
详细
|
ethyl 3-(2-(chloroMethyl)-1-Methyl-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate |
达比加群酯中间体3 |
1307233-94-8 |
详细
|
Dabigatran Etexilate iMpurity H |
达比加群酯杂质H |
1702936-92-2 |
详细
|
Dabigatran Impurity 10 |
达比加群脂杂质10 |
1422435-37-7 |
详细
|
Linagliptin N-Acetyl Impurity |
利格列汀N-乙酰杂质 |
1803079-49-3 |
详细
|
2,2'-((piperazine-1,4-disulfonyl)bis(2-ethoxy-5,1-phenylene))bis(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one) |
伐地那非杂质D |
1255919-03-9 |
详细
|
Linagliptin Impurity 33 |
利格列汀杂质33 |
2443735-53-1 |
详细
|
VARDENAFIL, DIHYDROCHLORIDE SALT |
伪伐地那非 |
224788-34-5 |
详细
|
Dibanzyloxy phosphatecreatinine |
二苄氧基磷酰基肌酸酐(磷酸肌酸钠杂质) |
19208-69-6 |
详细
|
Linagliptin Impurity 3 |
利格列汀杂质3 |
2749409-37-6 |
详细
|
oxiracetam impurity IV |
奥拉西坦杂质IV |
77191-37-8 |
详细
|
1-METHYLHYDANTOIN |
甲酰乙内脲 |
616-04-6 |
详细
|
N,N-DIMETHYL-GUANIDINE |
1,1-二甲基胍(磷酸肌酸钠杂质) |
6145-42-2 |
详细
|
Dabigatran Etexilate iMpurity O |
达比加群酯杂质O |
1349500-09-9 |
详细
|
Dabigatran iMpurity E |
达比加群杂质E |
1456889-80-7 |
详细
|
Dabigatran Impurity p |
达比加群酯杂质F |
1408238-37-8 |
详细
|
Linagliptin Impurity K |
利格列汀杂质K |
1638744-06-5 |
详细
|
ethyl benzofuran-6-carboxylate |
立他司特杂质32 |
1289646-90-7 |
详细
|
N-Desethyl-N-Methyl Vardenafil |
N-去乙基-N-甲基伐地那非(伐地那非杂质) |
224785-87-9 |
详细
|
Vardenafil Impurity 13 |
伐地那非杂质13 |
2169247-39-4 |
详细
|
Dabigatran Impurity 24 |
达比加群酯杂质24(达比加群酯杂质) |
2243727-83-3 |
详细
|
N-[1-[3-(2-Ethoxyphenyl)-2,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl]acetamide |
伐地那非杂质 |
1417529-59-9 |
详细
|
Dabigatran Impurity |
达比加群杂质 |
2096992-14-0 |
详细
|
1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-(methylamino)-1-[(4-methyl-2-quinazolinyl)methyl]- |
7-(丁-2-炔-1-基)-3-甲基-8-(甲基氨基)-1-((4-甲基喹唑啉-2-基)甲基)-1H-嘌呤-2,6-(3H,7H)-二酮(利格列汀杂质) |
2468656-63-3 |
详细
|
C3-NITRO-4-METHYLAMINO-BENZOYLCHLORIDE |
3-硝基-4-甲胺基-苯甲酰氯(达比加群杂质) |
82357-48-0 |
详细
|
INDEX NAME NOT YET ASSIGNED |
利格列汀杂质 |
2748491-45-2 |
详细
|
Acetylvardenafil |
乙酰伐地那非 |
1261351-28-3 |
详细
|
oxiracetaM related substance ISF3886 |
奥拉西坦进口标准杂质ISF3886 |
120428-80-0 |
详细
|
Linagliptin Impurity D |
利格列汀杂质D |
666816-91-7 |
详细
|
Linagliptin Impurity H |
利格列汀杂质H |
1646355-34-1 |
详细
|
1-Methylguanidine hydrochloride |
1-甲基胍盐酸盐(磷酸肌酸钠杂质) |
21770-81-0 |
详细
|
Dabigatran Etexilate Impurity 64 |
达比加群酯杂质64 |
355809-32-4 |
详细
|
Dabigatran Etexilate Impurity 82 |
达比加群酯杂质82 |
1771756-20-7 |
详细
|
oxiracetam impurity VII |
奥拉西坦杂质VII |
62613-81-4 |
详细
|
1H-Benzimidazole-5-carboxylic acid, 2-[[(4-cyanophenyl)amino]methyl]-1-methyl-, methyl ester |
达比加群酯杂质 |
1970195-83-5 |
详细
|
Dabigatran Etexilate iMpurity D |
达比加群酯杂质D |
1422435-40-2 |
详细
|
Dabigatran Etexilate iMpurity I |
达比加群乙二酸杂质I |
255706-13-9 |
详细
|
N-[3-AMino-4-(MethylaMino)benzoyl]-N-2-pyridinyl-β-alanine Methyl Ester |
达比加群酯杂质 |
1369510-38-2 |
详细
|
Dabigatran Etexilate Impurity H |
达比加群酯杂质H |
211915-00-3 |
详细
|
2-QuinazolineMethanol, 4-Methyl- |
利拉利汀杂质N |
13535-91-6 |
详细
|
Dabigatran Etexilate iMpurity 1 |
达比加群酯杂质1 |
1610758-19-4 |
详细
|
Dabigabine mesylate - intermediate 2 |
达比加群酯杂质O盐酸盐 |
1223061-75-3 |
详细
|
Dabigatran etexilate Impurity R |
达比加群乙二酸杂质R(达比加群酯杂质) |
1610758-20-7 |
详细
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-ethyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl- |
N-氧化伐地那非(伐地那非杂质) |
448184-48-3 |
详细
|
Dabigatran Impurity 16 |
达比加群杂质10 |
211916-39-1 |
详细
|
Dabigatran Impurity 5 |
达比加群酯杂质5 |
2225986-95-6 |
详细
|
Dabigatran Impurity 19 |
达比加群杂质 19 |
2225986-94-5 |
详细
|
Clobetasone |
氯倍他松 |
54063-32-0 |
详细
|